Stock DXCM DEXCOM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs DexCom, Inc.

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
124.3 USD -9.91% Intraday chart for DexCom, Inc. -4.87% +0.20%
Apr. 26 Wall Street: the worst week of 2024 is followed by the best CF
Apr. 26 Morgan Stanley Adjusts DexCom's Price Target to $132 From $122 MT

ETFs positioned on DexCom, Inc.

Name Weight AuM 1st Jan change Investor Rating
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
1.46% 18 M€ +3.79% -
HAN-GINS INDXX HEALTHCARE MEGATREND EQUAL WEIGHT UCITS ETF - ACC - USD ETF HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Acc - USD
1.04% 16 M€ -8.49%
DIREXION NASDAQ-100 EQUAL WEIGHTED ETF - USD ETF Direxion NASDAQ-100 Equal Weighted ETF - USD
0.96% 1,182 M€ +1.06%
WISDOMTREE U.S. GROWTH & MOMENTUM FUND ETF - USD ETF WisdomTree U.S. Growth & Momentum Fund ETF - USD
0.95% 2 M€ -1.17% -
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD Hedged
0.77% 2 M€ +6.77%
IQ U.S. MID CAP R&D LEADERS ETF - USD ETF IQ U.S. Mid Cap R&D Leaders ETF - USD
0.61% 4 M€ +20.15%
ADVOCATE RISING RATE HEDGE ETF - USD ETF Advocate Rising Rate Hedge ETF - USD
0.40% 5 M€ -72.95% -
LEVERAGE SHARES -3X SHORT US TECH 100 ETP SECURITIES - USD ETF Leverage Shares -3x Short US Tech 100 ETP Securities - USD
0.40% 3 M€ 0.00% -
ARMOR US EQUITY INDEX ETF - USD ETF Armor US Equity Index ETF - USD
0.36% 9 M€ -.--% -
LEVERAGE SHARES 5X LONG US TECH 100 ETP SECURITIES - USD ETF Leverage Shares 5x Long US Tech 100 ETP Securities - USD
0.31% 22 M€ 0.00% -
CSIF (IE) MSCI USA TECH 125 ESG UNIVERSAL BLUE UCITS ETF B - USD ETF CSIF (IE) MSCI USA Tech 125 ESG Universal Blue UCITS ETF B - USD
0.31% 40 M€ -.--%
AMUNDI MSCI USA ESG LEADERS SELECT UCITS ETF DR (C) - EUR HEDGED ETF Amundi MSCI USA ESG Leaders Select UCITS ETF DR (C) - EUR Hedged
0.28% 219 M€ +17.17% -
AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD ETF AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD
0.28% 1,448 M€ -.--% -
CSIF (IE) MSCI USA ESG LEADERS BLUE UCITS ETF - B - USD ETF CSIF (IE) MSCI USA ESG Leaders Blue UCITS ETF - B - USD
0.25% 2,510 M€ +12.00%
LYXOR MSCI USA ESG LEADERS EXTRA (DR) UCITS ETF - ACC - USD ETF Lyxor MSCI USA ESG Leaders Extra (DR) UCITS ETF - Acc - USD
0.21% 330 M€ -.--% -
ISHARES ESG MSCI USA LEADERS INDEX ETF - CAD ETF iShares ESG MSCI USA Leaders Index ETF - CAD
0.19% 2 M€ +14.69% -
AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD
0.17% 276 M€ +11.40% -
LYXOR MSCI USA CLIMATE CHANGE UCITS ETF - USD ETF Lyxor MSCI USA Climate Change UCITS ETF - USD
0.17% 36 M€ -.--%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR ETF CSIF (IE) MSCI World ESG Leaders Blue UCITS ETF - BH - EUR
0.17% 277 M€ -.--% -
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF ETF CSIF (IE) MSCI World ESG Leaders Blue UCITS ETF - BH - CHF
0.17% 194 M€ +7.48% -
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD ETF CSIF (IE) MSCI World ESG Leaders Blue UCITS ETF - B - USD
0.17% 441 M€ +10.26%
NOMURA NEXT FUNDS NASDAQ-100 ETF - JPY ETF Nomura NEXT FUNDS NASDAQ-100 ETF - JPY
0.15% 374 M€ +15.20% -
REVERE SECTOR OPPORTUNITY ETF - USD ETF Revere Sector Opportunity ETF - USD
0.14% 6 M€ +17.98% -
1234

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-07-24 - Q2 2024 Earnings Release (Projected)
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for DexCom, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
124.3 USD
Average target price
150 USD
Spread / Average Target
+20.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.52B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. DXCM Stock
  4. Funds and ETFs DexCom, Inc.